• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利血友病患者 1990-2007 年的死亡率和死因。

Mortality and causes of death in Italian persons with haemophilia, 1990-2007.

机构信息

Regional Reference Centre for Inherited Bleeding Disorders, University Hospital, Parma, Italy.

出版信息

Haemophilia. 2010 May;16(3):437-46. doi: 10.1111/j.1365-2516.2009.02188.x. Epub 2010 Feb 9.

DOI:10.1111/j.1365-2516.2009.02188.x
PMID:20148978
Abstract

Although a number of studies have analysed so far the causes of death and the life expectancy in haemophilic populations, no investigations have been conducted among Italian haemophilia centres. Thus, the aim of this study was to investigate mortality, causes of deaths, life expectancy and co-morbidities in Italian persons with haemophilia (PWH). Data pertaining to a total of 443 PWH who died between 1980 and 2007 were retrospectively collected in the 30 centres who are members of the Italian Association of Haemophilia Centres that chose to participate. The mortality rate ratio standardized to the male Italian population (SMR) was reduced during the periods 1990-1999 and 2000-2007 such that during the latter, death rate overlapped that of the general population (SMR 1990-1999: 1.98 95% CI 1.54-2.51; SMR 2000-2007: 1.08 95% CI 0.83-1.40). Similarly, life expectancy in the whole haemophilic population increased in the same period (71.2 years in 2000-2007 vs. 64.0 in 1990-1999), approaching that of the general male population. While human immunodeficiency virus infection was the main cause of death (45%), 13% of deaths were caused by hepatitis C-associated complications. The results of this retrospective study show that in Italian PWH improvements in the quality of treatment and global medical care provided by specialized haemophilia centres resulted in a significantly increased life expectancy.

摘要

尽管目前已有多项研究分析了血友病患者的死亡原因和预期寿命,但意大利的血友病中心尚未开展此类调查。因此,本研究旨在调查意大利血友病患者(PWH)的死亡率、死亡原因、预期寿命和合并症。在选择参与的意大利血友病中心协会的 30 个中心中,回顾性收集了 1980 年至 2007 年间总共 443 名死亡的 PWH 的数据。1990-1999 年和 2000-2007 年期间,标准化死亡率与意大利男性人口(SMR)的比值降低,使得后者的死亡率与普通人群重叠(SMR 1990-1999:1.98,95%CI 1.54-2.51;SMR 2000-2007:1.08,95%CI 0.83-1.40)。同样,同一时期整个血友病患者的预期寿命也有所增加(2000-2007 年为 71.2 岁,1990-1999 年为 64.0 岁),接近普通男性人口的预期寿命。尽管人类免疫缺陷病毒感染是主要的死亡原因(45%),但仍有 13%的死亡归因于丙型肝炎相关并发症。本回顾性研究的结果表明,意大利 PWH 的治疗质量和由专业血友病中心提供的整体医疗护理得到改善,从而显著提高了预期寿命。

相似文献

1
Mortality and causes of death in Italian persons with haemophilia, 1990-2007.意大利血友病患者 1990-2007 年的死亡率和死因。
Haemophilia. 2010 May;16(3):437-46. doi: 10.1111/j.1365-2516.2009.02188.x. Epub 2010 Feb 9.
2
Effects of HIV infection on age and cause of death for persons with hemophilia A in the United States.美国艾滋病病毒感染对甲型血友病患者年龄及死因的影响。
Am J Hematol. 2001 Apr;66(4):229-40. doi: 10.1002/ajh.1050.
3
Survival in a cohort of patients with haemophilia at the haemophilia care center in Vienna, Austria, from 1983 to 2006.1983 年至 2006 年期间,在奥地利维也纳血友病护理中心的血友病患者队列中的生存情况。
Haemophilia. 2009 Jul;15(4):888-93. doi: 10.1111/j.1365-2516.2009.02029.x. Epub 2009 Apr 7.
4
Does haemophilia influence cancer-related mortality in HIV-negative patients?血友病是否会影响 HIV 阴性患者的癌症相关死亡率?
Haemophilia. 2011 Jan;17(1):55-60. doi: 10.1111/j.1365-2516.2010.02364.x. Epub 2010 Aug 16.
5
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors.意大利血友病患者伴与不伴抑制剂的颅内出血。
Haemophilia. 2012 Jan;18(1):39-45. doi: 10.1111/j.1365-2516.2011.02611.x. Epub 2011 Jul 14.
6
Mortality of patients with haemophilia in Brazil: First report.巴西血友病患者死亡率:首次报告。
Haemophilia. 2019 May;25(3):e146-e152. doi: 10.1111/hae.13730. Epub 2019 Mar 15.
7
Mortality after discharge from acute care hospitalization with traumatic brain injury: a population-based study.创伤性脑损伤患者急性住院治疗出院后的死亡率:一项基于人群的研究。
Arch Phys Med Rehabil. 2010 Jan;91(1):20-9. doi: 10.1016/j.apmr.2009.08.151.
8
Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.希腊血友病HIV阳性患者队列在高效抗逆转录病毒治疗(HAART)时代后的HIV感染进展情况。
Haemophilia. 2005 Jul;11(4):360-5. doi: 10.1111/j.1365-2516.2005.01109.x.
9
[Causes of death in patients with haemophilia in Germany 2006/2007].[2006/2007年德国血友病患者的死因]
Hamostaseologie. 2008 Oct;28 Suppl 1:S5-11.
10
Co-morbidities and quality of life in elderly persons with haemophilia.老年血友病患者的合并症和生活质量。
Br J Haematol. 2010 Feb;148(4):522-33. doi: 10.1111/j.1365-2141.2009.08005.x. Epub 2009 Dec 1.

引用本文的文献

1
Haemophilia and Cancer: A Literature Review.血友病与癌症:文献综述
J Clin Med. 2024 Mar 19;13(6):1770. doi: 10.3390/jcm13061770.
2
Cardiovascular Risk Scores among Asymptomatic Adults with Haemophilia.无症状血友病成人的心血管风险评分。
Arq Bras Cardiol. 2023 Sep 18;120(9):e20230004. doi: 10.36660/abc.20230004. eCollection 2023.
3
Association of Genetic Variant FVIII Gene and Factor VIII: A Pilot Study Among Hemophilia A Female Relatives in Saudi Arabia.FVIII基因遗传变异与凝血因子VIII的关联:沙特阿拉伯A型血友病女性亲属的一项初步研究。
Cureus. 2023 Jul 17;15(7):e42038. doi: 10.7759/cureus.42038. eCollection 2023 Jul.
4
Hemophilia patients: are they naturally anticoagulated?血友病患者:他们是否天生具有抗凝作用?
Intern Emerg Med. 2023 Aug;18(5):1251-1254. doi: 10.1007/s11739-023-03331-7. Epub 2023 Jul 29.
5
Successful initiation of hemodialysis for a hemophilia A patient with factor VIII inhibitor: a case report and literature review.成功为一名伴有因子 VIII 抑制剂的血友病 A 患者启动血液透析:病例报告及文献复习。
CEN Case Rep. 2024 Apr;13(2):117-120. doi: 10.1007/s13730-023-00811-9. Epub 2023 Jul 25.
6
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review.血友病患者与普通人群中特定出血和血栓形成事件的患病率:一项范围综述。
Res Pract Thromb Haemost. 2022 Dec 9;7(1):100007. doi: 10.1016/j.rpth.2022.100007. eCollection 2023 Jan.
7
How we manage cardiovascular disease in patients with hemophilia.我们如何管理血友病患者的心血管疾病。
Haematologica. 2023 Jul 1;108(7):1748-1757. doi: 10.3324/haematol.2022.282407.
8
Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management.血友病患者的丙型肝炎病毒感染:关联、风险与管理
J Multidiscip Healthc. 2022 Oct 10;15:2301-2309. doi: 10.2147/JMDH.S363177. eCollection 2022.
9
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.非重度血友病患者凝血因子替代产品的预防应用:文献综述。
Haemophilia. 2023 Jan;29(1):33-44. doi: 10.1111/hae.14676. Epub 2022 Oct 12.
10
Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders.奥比他韦/帕利瑞韦/利托那韦+达沙布韦±利巴韦林联合治疗 1 型丙型肝炎合并遗传性出血性疾病患者的疗效和安全性。
Turk J Gastroenterol. 2022 May;33(5):414-420. doi: 10.5152/tjg.2022.20844.